Dr Agarwals Eye Hospital Ltd.

3339.00 -69.60 ▼-2.0%

21 February 2024, 04:01:00 PM
Volume: 669

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Industry Icon Hospital & Healthcare Services Compare with Industry peers
Website http://www.dragarwal.com
Market Cap 1,575.58 Cr.
Enterprise Value(EV) 1,577.39 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 100.53 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 33.35 Trailing Twelve Months Ending 2023-12
Industry PE 70.77 Trailing Twelve Months Ending 2023-12
Book Value / Share 311.55 Trailing Twelve Months Ending 2023-12
Price to Book Value 10.76 Calculated using Price: 3,352.30
Dividend Yield 0.09 Period Ending 2023-03
No. of Shares Subscribed 0.47 Cr. 4,700,000 Shares
FaceValue 10
About Dr Agarwals Eye Hospital Ltd.
Dr.Agarwal's Eye Hospital has been promoted by Dr.J.Agarwal and his family members in 1994. Though the entire family has been in the profession of providing total eye care solutions for almost five decades prior to this, through various private limited company and partnership firms, owned by the family members. The Hospital has always been at the forefront of every medical advancement in the field of Ophthalmic care in the world and has several firsts to its credit. The Hospital is engaged in conducting continuous training and research and development programs and has over a period, developed an excellent team of highly skilled Ophthalmic specialists and surgeons, to assist in its growth plans.

Dr Agarwals Eye Hospital Ltd. Delivery

Delivered Qty
Traded Qty

Dr Agarwals Eye Hospital Ltd. Performance

1 Day
-2.04%
1 Week
+0.77%
1 Month
+11.19%
3 Month
+19.40%
6 Month
+48.62%
1 Year
+242.62%
2 Year
+288.55%
5 Year
+800%
10 Year
+4810.29%

Dr Agarwals Eye Hospital Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 26.67 0.16 27.78 21.02 29.55 26.91 -2.6 36.29 38.56
Return on Capital Employed (%) 18.81 7.7 28.26 31.7 34.3 39.87 16.92 42.4 42.98
Return on Assets (%) 8.53 0.05 8.87 7.65 11.01 9.55 -0.86 9.63 9.78

Dr Agarwals Eye Hospital Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 24 23 29 35 46 56 55 78 113 137
Non Curr. Liab. 13 25 24 24 40 71 42 173 212 217
Curr. Liab. 31 36 27 37 35 39 70 82 96 63
Minority Int.
Equity & Liab. 67 84 81 96 120 166 167 333 422 417
Non Curr. Assets 44 61 61 73 91 136 123 283 375 358
Curr. Assets 23 24 20 23 30 30 44 50 47 59
Misc. Exp. not W/O
Total Assets 67 84 81 96 120 166 167 333 422 417

Dr Agarwals Eye Hospital Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 118 137 149 153 170 176 140 201 268 306
Other Income 0 0 2 2 2 3 2 1 2 5
Total Income 118 137 150 156 172 179 142 202 270 311
Total Expenditure -103 -121 -126 -129 -140 -129 -110 -143 -192 -220
PBIDT 15 15 24 27 32 50 32 60 78 91
Interest -4 -5 -4 -3 -4 -9 -7 -7 -8 -7
Depreciation -6 -11 -9 -10 -11 -21 -19 -20 -20 -21
Taxation 0 1 -4 -7 -6 -6 -7 -8 -12 -16
Exceptional Items
PAT 6 0 7 7 12 14 -1 24 37 47
Adjusted EPS 12 0 16 14 25 29 -3 51 79 101

Dr Agarwals Eye Hospital Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 12 14 17 20 19 25 39 34 57 70
Cash Fr. Inv. -11 -10 -17 -8 -11 -25 -17 -11 -46 -71
Cash Fr. Finan. -3 -5 0 -12 -8 2 -20 -8 -4 0
Net Change -3 -1 0 0 0 2 2 15 7 -1
Cash & Cash Eqvt 3 1 2 2 2 4 6 22 28 27

Dr Agarwals Eye Hospital Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 72.38 72.15 72.00 71.91 71.90 71.90 71.90 71.90 71.90
Public 27.62 27.85 28.00 28.09 28.10 28.10 28.10 28.10 28.10
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 99.14 98.44 59.76 59.84 99.80 99.80 99.80 39.95 39.95

Dr Agarwals Eye Hospital Ltd. Announcements

Fri, 09 Feb 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Disclosure under Regulation 39(3) of the SEBI (LODR) Regulations 2015 is submitted.
Thu, 08 Feb 2024
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Disclosure of commencement of operation of a new unit is submitted.
Tue, 06 Feb 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Disclosure under Regulation 39(3) of the SEBI (LODR) Regulations 2015 is submitted.

Dr Agarwals Eye Hospital Ltd. Technical Scans

Wed, 21 Feb 2024
High Delivery Percentage High Delivery Percentage
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months

Dr Agarwals Eye Hospital Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 370,313.36 1,543.40 +0.3%
Cipla Ltd. 116,866.14 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. 105,898.11 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. 97,179.74 6,760.15 +0.0%
Divi's Laboratories Ltd. 96,854.88 3,649.10 -1.7%
Zydus Lifesciences Ltd. 90,440.44 893.80 -0.2%
Torrent Pharmaceuticals Ltd. 88,043.20 2,603.00 -1.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.58 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-12 31.52 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.26 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.12 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 70.03 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-12 30.41 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 58.93 2,603.00 -1.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.94 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-12 4.51 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.94 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.39 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.43 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.65 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.31 2,603.00 -1.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,603.00 -1.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,603.00 -1.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,603.00 -1.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,603.00 -1.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,543.40 +0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,447.30 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,349.15 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,760.15 +0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,649.10 -1.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 893.80 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,603.00 -1.6%

Dr Agarwals Eye Hospital Ltd. FAQ's

What is Dr Agarwals Eye Hsp share price?

Can I buy Dr Agarwals Eye Hsp shares now?

What is the Dividend Yield of Dr Agarwals Eye Hsp?

What is the Market Cap of Dr Agarwals Eye Hsp?

What are the key metrics to analyse Dr Agarwals Eye Hsp?

What is the 52 Week High and Low of Dr Agarwals Eye Hsp?

What is the trend of Dr Agarwals Eye Hsp share price?